apomorphine has been researched along with Atrophy in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cash, D; Mesquita, M; Simmons, C; Sumiyoshi, A; Vernon, AC; Westphal, R; Williams, SC; Wood, TC | 1 |
| Snider, SR | 1 |
| Jansen, EM; Low, WC | 1 |
| Arnold, G; Gasser, T; Oertel, WH; Schwarz, J; Tatsch, K | 1 |
| Björklund, A; Devaux, B; Kirik, D; Moffat, B; Phillips, HS; Rosenblad, C | 1 |
| Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK | 1 |
| Behzadi, G; Roghani, M | 1 |
| Colosimo, C; Daniel, SE; Hughes, AJ; Kleedorfer, B; Lees, AJ | 1 |
| Court, J; Godoy, J; Valenzuela, R | 1 |
| Artieda, J; Luquin, MR; Martínez Lage, JM; Obeso, JA; Tuñón, T | 1 |
1 review(s) available for apomorphine and Atrophy
| Article | Year |
|---|---|
Cerebellar pathology in schizophrenia--cause or consequence?
Topics: Animals; Apomorphine; Atrophy; Behavior, Animal; Brain Stem; Cats; Cerebellar Diseases; Cerebellum; Dopamine; Haloperidol; Humans; Hypothalamus; Limbic System; Locus Coeruleus; Motor Activity; Neural Pathways; Rats; Schizophrenia | 1982 |
1 trial(s) available for apomorphine and Atrophy
| Article | Year |
|---|---|
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
Topics: Adult; Aged; Apomorphine; Atrophy; Benzamides; Binding Sites; Cerebral Cortex; Dopamine; Dopamine Agonists; Dopamine Antagonists; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1997 |
8 other study(ies) available for apomorphine and Atrophy
| Article | Year |
|---|---|
Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
Topics: Animals; Apomorphine; Atrophy; Brain; Dopamine Agonists; Dopaminergic Neurons; Functional Laterality; Gray Matter; Immunohistochemistry; Magnetic Resonance Imaging; Male; Motor Activity; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2016 |
Long-term effects of neonatal ischemic-hypoxic brain injury on sensorimotor and locomotor tasks in rats.
Topics: Animals; Animals, Newborn; Apomorphine; Atrophy; Brain; Brain Ischemia; Dopamine Agonists; Female; Functional Laterality; Hypoxia, Brain; Locomotion; Male; Postural Balance; Rats; Rats, Wistar; Rotation | 1996 |
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Topics: Amphetamine; Animals; Antibodies; Apomorphine; Atrophy; Body Weight; Cerebral Ventricles; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; ELAV Proteins; Female; Glial Cell Line-Derived Neurotrophic Factor; Hydrogen-Ion Concentration; Injections, Intraventricular; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Neurturin; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1999 |
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Autoradiography; Behavior, Animal; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Fetal Tissue Transplantation; Male; Mazindol; Nerve Degeneration; Neurons; Oxidopamine; Quinolinic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra; Sympatholytics; Tritium | 2000 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Animal; Male; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Vitamin E; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2001 |
The dopaminergic response in multiple system atrophy.
Topics: Adult; Aged; Apomorphine; Atrophy; Brain Stem; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Terminology as Topic | 1992 |
Delayed cyanide induced dystonia.
Topics: Adolescent; Adult; Apomorphine; Atrophy; Brain Damage, Chronic; Cerebral Cortex; Dystonia; Electroencephalography; Follow-Up Studies; Humans; Levodopa; Male; Neurologic Examination; Potassium Cyanide; Putamen; Reaction Time | 1992 |
Dopamine agonists suppress visual-cortical reflex myoclonus.
Topics: Aged; Apomorphine; Atrophy; Carbidopa; Cerebellum; Drug Therapy, Combination; Electromyography; Epilepsies, Myoclonic; Ergolines; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Levodopa; Lisuride; Olivary Nucleus; Photic Stimulation; Pons; Reflex; Visual Cortex | 1985 |